Sanofi
SNY
602 hedge funds and large institutions have $8.52B invested in Sanofi in 2020 Q4 according to their latest regulatory filings, with 93 funds opening new positions, 182 increasing their positions, 220 reducing their positions, and 56 closing their positions.
80% more call options, than puts
Call options by funds: $46.5M | Put options by funds: $25.8M
66% more first-time investments, than exits
New positions opened: 93 | Existing positions closed: 56
5% more funds holding
Funds holding: 573 → 602 (+29)
0.12% more ownership
Funds ownership: 13.79% → 13.9% (+0.12%)
2% less capital invested
Capital invested by funds: $8.71B → $8.52B (-$191M)
17% less repeat investments, than reductions
Existing positions increased: 182 | Existing positions reduced: 220
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$92.4M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$78.6M |
| 3 |
Dodge & Cox
San Francisco,
California
|
+$31.1M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$27.6M |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$22.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$56.2M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$55.4M |
| 3 |
Fisher Asset Management
Camas,
Washington
|
-$20.2M |
| 4 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
-$16.5M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$14.8M |
SNY Hedge Fund Activity: Q4 2020 in Review
602 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q4 2020, worth a combined $8.52B — down 2.2% from $8.71B a quarter earlier.
Buyers outnumbered sellers: 93 funds opened new SNY positions and 56 closed out — a net gain of 37 holders — while 182 added to existing stakes and 220 trimmed.
The largest buyer was Hotchkis & Wiley Capital Management, adding an estimated $92.4M. The largest seller was Sphera Funds Management, exiting entirely with an estimated $56.2M sold.
- 602 institutional investors held Sanofi (SNY) as of Q4 2020, up from 573 in Q3 2020.
- Funds reported $8.52B of Sanofi stock for Q4 2020, down 2.2% quarter-over-quarter.
- 93 funds opened new Sanofi positions in Q4 2020 and 56 closed out, a net change of +37 holders.
- The largest Sanofi buyer in Q4 2020 was Hotchkis & Wiley Capital Management, an estimated $92.4M added.
- The largest Sanofi seller in Q4 2020 was Sphera Funds Management, an estimated $56.2M sold.
Based on aggregated 13F filings for Q4 2020.